{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T06:15:21Z","timestamp":1795241721077,"version":"4.10.3"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T00:00:00Z","timestamp":1706832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T00:00:00Z","timestamp":1706832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018R1A3B1052702"],"award-info":[{"award-number":["2018R1A3B1052702"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00273030"],"award-info":[{"award-number":["RS-2023-00273030"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2021R1A2C2093916"],"award-info":[{"award-number":["NRF-2021R1A2C2093916"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2014M3C7A1046041"],"award-info":[{"award-number":["NRF-2014M3C7A1046041"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Amyloid-\u03b2 (A\u03b2) oligomers are implicated in the onset of Alzheimer\u2019s disease (AD). Herein, quinoline-derived half-curcumin-dioxaborine (Q-OB) fluorescent probe was designed for detecting A\u03b2 oligomers by finely tailoring the hydrophobicity of the biannulate donor motifs in donor-\u03c0-acceptor structure. Q-OB shows a great sensing potency in dynamically monitoring oligomerization of A\u03b2 during amyloid fibrillogenesis in vitro. In addition, we applied this strategy to fluorometrically analyze A\u03b2 self-assembly kinetics in the cerebrospinal fluids (CSF) of AD patients. The fluorescence intensity of Q-OB in AD patients\u2019 CSF revealed a marked change of log (\n                    <jats:italic>I<\/jats:italic>\n                    \/\n                    <jats:italic>I<\/jats:italic>\n                    <jats:sub>\n                      <jats:italic>0<\/jats:italic>\n                    <\/jats:sub>\n                    ) value of 0.34\u2009\u00b1\u20090.13 (cognitive normal), 0.15\u2009\u00b1\u20090.12 (mild cognitive impairment), and 0.14\u2009\u00b1\u20090.10 (AD dementia), guiding to distinguish a state of AD continuum for early diagnosis of AD. These studies demonstrate the potential of our approach can expand the currently available preclinical diagnostic platform for the early stages of AD, aiding in the disruption of pathological progression and the development of appropriate treatment strategies.\n                  <\/jats:p>","DOI":"10.1038\/s41467-024-44818-x","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T12:02:32Z","timestamp":1706875352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["Early onset diagnosis in Alzheimer\u2019s disease patients via amyloid-\u03b2 oligomers-sensing probe in cerebrospinal fluid"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4324-2782","authenticated-orcid":false,"given":"Jusung","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeonghwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0115-5170","authenticated-orcid":false,"given":"Ho Jae","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3757-5652","authenticated-orcid":false,"given":"Hye Yun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3687-6448","authenticated-orcid":false,"given":"Jinwoo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"InWook","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Illhwan","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeong Yun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1570-3230","authenticated-orcid":false,"given":"Sunghoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0302-5727","authenticated-orcid":false,"given":"Catriona","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu Yeong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5029-7082","authenticated-orcid":false,"given":"YoungSoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4144-8162","authenticated-orcid":false,"given":"Kun Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3477-1172","authenticated-orcid":false,"given":"Jong Seung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,2]]},"reference":[{"key":"44818_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy, J. & Selkoe, D. J. The amyloid hypothesis of alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297, 353\u2013356 (2002).","journal-title":"Science"},{"key":"44818_CR2","doi-asserted-by":"publisher","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","volume":"1","author":"CL Masters","year":"2015","unstructured":"Masters, C. L. et al. Alzheimer\u2019s disease. Nat. Rev. Dis. Prim. 1, 15056 (2015).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"44818_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3233\/JAD-2010-1221","volume":"19","author":"MP Murphy","year":"2010","unstructured":"Murphy, M. P. & LeVine Iii, H. Alzheimer\u2019s disease and the amyloid-\u03b2 peptide. J. Alzheimer\u2019s Dis. 19, 311\u2013323 (2010).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"44818_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack","year":"2013","unstructured":"Jack, C. R. et al. Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 12, 207\u2013216 (2013).","journal-title":"Lancet Neurol."},{"key":"44818_CR5","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/aps.2017.28","volume":"38","author":"G-F Chen","year":"2017","unstructured":"Chen, G.-F. et al. Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol. Sin. 38, 1205\u20131235 (2017).","journal-title":"Acta Pharmacol. Sin."},{"key":"44818_CR6","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1097\/00005072-199655100-00001","volume":"55","author":"RD Terry","year":"1996","unstructured":"Terry, R. D. The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. J. Neuropathol. Exp. Neurol. 55, 1023\u20131025 (1996).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"44818_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass, C. & Selkoe, D. J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid \u03b2-peptide. Nat. Rev. Mol. Cell Biol. 8, 101\u2013112 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"44818_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nn1372","volume":"8","author":"JP Cleary","year":"2005","unstructured":"Cleary, J. P. et al. Natural oligomers of the amyloid-\u03b2 protein specifically disrupt cognitive function. Nat. Neurosci. 8, 79\u201384 (2005).","journal-title":"Nat. Neurosci."},{"key":"44818_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nn.3028","volume":"15","author":"I Benilova","year":"2012","unstructured":"Benilova, I., Karran, E. & De Strooper, B. The toxic A\u03b2 oligomer and Alzheimer\u2019s disease: an emperor in need of clothes. Nat. Neurosci. 15, 349\u2013357 (2012).","journal-title":"Nat. Neurosci."},{"key":"44818_CR10","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","volume":"46","author":"CA McLean","year":"1999","unstructured":"McLean, C. A. et al. Soluble pool of A\u03b2 amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disease. Ann. Neurol. 46, 860\u2013866 (1999).","journal-title":"Ann. Neurol."},{"key":"44818_CR11","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","volume":"155","author":"L-F Lue","year":"1999","unstructured":"Lue, L.-F. et al. Soluble amyloid \u03b2 peptide concentration as a predictor of synaptic change in Alzheimer\u2019s disease. Am. J. Clin. Pathol. 155, 853\u2013862 (1999).","journal-title":"Am. J. Clin. Pathol."},{"key":"44818_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny, J. et al. The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nature 537, 50\u201356 (2016).","journal-title":"Nature"},{"key":"44818_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2022","unstructured":"van Dyck, C. H. et al. Lecanemab in early Alzheimer\u2019s disease. N. Engl. J. Med. 388, 9\u201321 (2022).","journal-title":"N. Engl. J. Med."},{"key":"44818_CR14","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","volume":"384","author":"MA Mintun","year":"2021","unstructured":"Mintun, M. A. et al. Donanemab in early Alzheimer\u2019s disease. N. Engl. J. Med. 384, 1691\u20131704 (2021).","journal-title":"N. Engl. J. Med."},{"key":"44818_CR15","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long, J. M. & Holtzman, D. M. Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179, 312\u2013339 (2019).","journal-title":"Cell"},{"key":"44818_CR16","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/cpt.200","volume":"98","author":"C Ising","year":"2015","unstructured":"Ising, C., Stanley, M. & Holtzman, D. M. Current thinking on the mechanistic basis of Alzheimer\u2019s and implications for drug development. Clin. Pharmacol. Ther. 98, 469\u2013471 (2015).","journal-title":"Clin. Pharmacol. Ther."},{"key":"44818_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.nic.2005.09.005","volume":"15","author":"MM Husain","year":"2005","unstructured":"Husain, M. M. & Garrett, R. K. Clinical diagnosis and management of Alzheimer\u2019s disease, 2nd edition. Neuroimaging Clin. N. Am. 15, 3\u201313 (2005).","journal-title":"Neuroimaging Clin. N. Am."},{"key":"44818_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13195-019-0499-7","volume":"11","author":"YC Youn","year":"2019","unstructured":"Youn, Y. C. et al. Blood amyloid-\u03b2 oligomerization associated with neurodegeneration of Alzheimer\u2019s disease. Alzheimer\u2019s Res. Ther. 11, 40 (2019).","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"44818_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4235\/agmr.20.0082","volume":"25","author":"H Jun","year":"2021","unstructured":"Jun, H., Cho, S. K., Yoong, J. & Mattke, S. Is Korea prepared for an Alzheimer\u2019s disease-modifying therapy? Assessing the Korean healthcare system infrastructure and the effect of blood-based biomarker tests. Ann. Geriatr. Med. Res. 25, 33\u201338 (2021).","journal-title":"Ann. Geriatr. Med. Res."},{"key":"44818_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bbrc.2021.08.066","volume":"576","author":"K Yamashita","year":"2021","unstructured":"Yamashita, K. et al. Fully automated chemiluminescence enzyme immunoassays showing high correlation with immunoprecipitation mass spectrometry assays for \u03b2-amyloid (1\u201340) and (1\u201342) in plasma samples. Biochem. Biophys. Res. Commun. 576, 22\u201326 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"44818_CR21","first-page":"563","volume":"10","author":"EAJ Willemse","year":"2018","unstructured":"Willemse, E. A. J. et al. Diagnostic performance of Elecsys immunoassays for cerebrospinal fluid Alzheimer\u2019s disease biomarkers in a nonacademic, multicenter memory clinic cohort: the ABIDE project. Alzheimer\u2019s Dement.: Diagn. Assess. Dis. Monit. 10, 563\u2013572 (2018).","journal-title":"Alzheimer\u2019s Dement.: Diagn. Assess. Dis. Monit."},{"key":"44818_CR22","doi-asserted-by":"publisher","first-page":"2001945","DOI":"10.1002\/adma.202001945","volume":"32","author":"J Zhou","year":"2020","unstructured":"Zhou, J. et al. Fluorescent diagnostic probes in neurodegenerative diseases. Adv. Mater. 32, 2001945 (2020).","journal-title":"Adv. Mater."},{"key":"44818_CR23","doi-asserted-by":"publisher","first-page":"8887","DOI":"10.1039\/D1CS00083G","volume":"50","author":"S Wang","year":"2021","unstructured":"Wang, S. et al. Fluorescence imaging of pathophysiological microenvironments. Chem. Soc. Rev. 50, 8887\u20138902 (2021).","journal-title":"Chem. Soc. Rev."},{"key":"44818_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1021\/acscentsci.8b00951","volume":"5","author":"YW Jun","year":"2019","unstructured":"Jun, Y. W. et al. Frontiers in probing Alzheimer\u2019s disease biomarkers with fluorescent small molecules. ACS Cent. Sci. 5, 209\u2013217 (2019).","journal-title":"ACS Cent. Sci."},{"key":"44818_CR25","first-page":"239","volume":"13","author":"J An","year":"2022","unstructured":"An, J. et al. Picomolar-sensitive \u03b2-amyloid fibril fluorophores by tailoring the hydrophobicity of biannulated \u03c0-elongated dioxaborine-dyes. Bioact. Mater. 13, 239\u2013248 (2022).","journal-title":"Bioact. Mater."},{"key":"44818_CR26","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.3390\/ijms21124477","volume":"21","author":"Y-R Huang","year":"2020","unstructured":"Huang, Y.-R. & Liu, R.-T. The toxicity and polymorphism of \u03b2-amyloid oligomers. Int. J. Mol. Sci. 21, 4477 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"44818_CR27","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1016\/j.bmcl.2013.01.065","volume":"23","author":"LP Jameson","year":"2013","unstructured":"Jameson, L. P. & Dzyuba, S. V. Aza-BODIPY: improved synthesis and interaction with soluble A\u03b21\u201342 oligomers. Bioorg. Med. Chem. Lett. 23, 1732\u20131735 (2013).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"44818_CR28","doi-asserted-by":"publisher","first-page":"13503","DOI":"10.1021\/jacs.5b06190","volume":"137","author":"CL Teoh","year":"2015","unstructured":"Teoh, C. L. et al. Chemical fluorescent probe for detection of A\u03b2 oligomers. J. Am. Chem. Soc. 137, 13503\u201313509 (2015).","journal-title":"J. Am. Chem. Soc."},{"key":"44818_CR29","doi-asserted-by":"publisher","first-page":"8279","DOI":"10.1039\/C7SC03974C","volume":"8","author":"Y Li","year":"2017","unstructured":"Li, Y. et al. Fluoro-substituted cyanine for reliable in vivo labelling of amyloid-\u03b2 oligomers and neuroprotection against amyloid-\u03b2 induced toxicity. Chem. Sci. 8, 8279\u20138284 (2017).","journal-title":"Chem. Sci."},{"key":"44818_CR30","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1039\/C9CC08894F","volume":"56","author":"J Yang","year":"2020","unstructured":"Yang, J. et al. Highly specific detection of A\u03b2 oligomers in early Alzheimer\u2019s disease by a near-infrared fluorescent probe with a \u201cV-shaped\u201d spatial conformation. Chem. Commun. 56, 583\u2013586 (2020).","journal-title":"Chem. Commun."},{"key":"44818_CR31","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1039\/C9CC09233A","volume":"56","author":"G Lv","year":"2020","unstructured":"Lv, G. et al. A novel near-infrared fluorescent probe for detection of early-stage A\u03b2 protofibrils in Alzheimer\u2019s disease. Chem. Commun. 56, 1625\u20131628 (2020).","journal-title":"Chem. Commun."},{"key":"44818_CR32","doi-asserted-by":"publisher","first-page":"131481","DOI":"10.1016\/j.snb.2022.131481","volume":"358","author":"H Li","year":"2022","unstructured":"Li, H. et al. Detection of A\u03b2 oligomers in early Alzheimer\u2019s disease diagnose by in vivo NIR-II fluorescence imaging. Sens. Actuator B-Chem. 358, 131481 (2022).","journal-title":"Sens. Actuator B-Chem."},{"key":"44818_CR33","doi-asserted-by":"publisher","first-page":"10462","DOI":"10.1021\/jacs.1c05470","volume":"143","author":"L Sun","year":"2021","unstructured":"Sun, L. et al. Amphiphilic distyrylbenzene derivatives as potential therapeutic and imaging agents for soluble and insoluble amyloid \u03b2 aggregates in Alzheimer\u2019s disease. J. Am. Chem. Soc. 143, 10462\u201310476 (2021).","journal-title":"J. Am. Chem. Soc."},{"key":"44818_CR34","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/psc.647","volume":"11","author":"M Hanyu","year":"2005","unstructured":"Hanyu, M. et al. Studies on intramolecular hydrogen bonding between the pyridine nitrogen and the amide hydrogen of the peptide: synthesis and conformational analysis of tripeptides containing novel amino acids with a pyridine ring. J. Pept. Sci. 11, 491\u2013498 (2005).","journal-title":"J. Pept. Sci."},{"key":"44818_CR35","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1021\/ja045558b","volume":"127","author":"P Rzepecki","year":"2005","unstructured":"Rzepecki, P. & Schrader, T. \u03b2-sheet ligands in action:\u2009 KLVFF recognition by aminopyrazole hybrid receptors in water. J. Am. Chem. Soc. 127, 3016\u20133025 (2005).","journal-title":"J. Am. Chem. Soc."},{"key":"44818_CR36","doi-asserted-by":"publisher","first-page":"9734","DOI":"10.1073\/pnas.1505420112","volume":"112","author":"X Zhang","year":"2015","unstructured":"Zhang, X. et al. Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer\u2019s disease. Proc. Natl Acad. Sci. USA 112, 9734\u20139739 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"44818_CR37","doi-asserted-by":"publisher","first-page":"5951","DOI":"10.1021\/jp8095727","volume":"113","author":"J Catal\u00e1n","year":"2009","unstructured":"Catal\u00e1n, J. Toward a generalized treatment of the solvent effect based on four empirical scales: dipolarity (SdP, a new scale), polarizability (SP), acidity (SA), and basicity (SB) of the medium. J. Phys. Chem. B 113, 5951\u20135960 (2009).","journal-title":"J. Phys. Chem. B"},{"key":"44818_CR38","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10847-021-01085-3","volume":"101","author":"J An","year":"2021","unstructured":"An, J. et al. Multichromatic fluorescence towards aberrant proteinaceous aggregates utilizing benzimidazole-based ICT fluorophores. J. Incl. Phenom. Macrocycl. Chem. 101, 205\u2013215 (2021).","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"44818_CR39","doi-asserted-by":"publisher","first-page":"6972","DOI":"10.1021\/acs.jmedchem.5b00861","volume":"58","author":"H Fu","year":"2015","unstructured":"Fu, H. et al. Highly sensitive near-infrared fluorophores for in vivo detection of amyloid-\u03b2 plaques in Alzheimer\u2019s disease. J. Med. Chem. 58, 6972\u20136983 (2015).","journal-title":"J. Med. Chem."},{"key":"44818_CR40","doi-asserted-by":"publisher","first-page":"8667","DOI":"10.1039\/C8CC02204F","volume":"54","author":"M T\u00f6rnquist","year":"2018","unstructured":"T\u00f6rnquist, M. et al. Secondary nucleation in amyloid formation. Chem. Commun. 54, 8667\u20138684 (2018).","journal-title":"Chem. Commun."},{"key":"44818_CR41","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s12551-017-0289-z","volume":"9","author":"S Linse","year":"2017","unstructured":"Linse, S. Monomer-dependent secondary nucleation in amyloid formation. Biophys. Rev. 9, 329\u2013338 (2017).","journal-title":"Biophys. Rev."},{"key":"44818_CR42","doi-asserted-by":"publisher","first-page":"16947","DOI":"10.1074\/jbc.M111.321778","volume":"287","author":"TM Ryan","year":"2012","unstructured":"Ryan, T. M. et al. Small amphipathic molecules modulate secondary structure and amyloid fibril-forming kinetics of Alzheimer disease peptide A\u03b21\u201342. J. Biol. Chem. 287, 16947\u201316954 (2012).","journal-title":"J. Biol. Chem."},{"key":"44818_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1021\/acschemneuro.2c00449","volume":"14","author":"I Cho","year":"2023","unstructured":"Cho, I. et al. Immobilized amyloid hexamer fragments to map active sites of amyloid-targeting chemicals. ACS Chem. Neurosci. 14, 9\u201318 (2023).","journal-title":"ACS Chem. Neurosci."},{"key":"44818_CR44","doi-asserted-by":"publisher","first-page":"16397","DOI":"10.1021\/ja405239v","volume":"135","author":"X Zhang","year":"2013","unstructured":"Zhang, X. et al. Design and synthesis of curcumin analogues for in vivo fluorescence imaging and inhibiting copper-induced cross-linking of amyloid beta species in Alzheimer\u2019s disease. J. Am. Chem. Soc. 135, 16397\u201316409 (2013).","journal-title":"J. Am. Chem. Soc."},{"key":"44818_CR45","doi-asserted-by":"publisher","first-page":"8104","DOI":"10.1039\/D2SC02819K","volume":"13","author":"B Zhu","year":"2022","unstructured":"Zhu, B. et al. Epitope alteration by small molecules and applications in drug discovery. Chem. Sci. 13, 8104\u20138116 (2022).","journal-title":"Chem. Sci."},{"key":"44818_CR46","doi-asserted-by":"publisher","first-page":"5892","DOI":"10.1074\/jbc.M404751200","volume":"280","author":"F Yang","year":"2005","unstructured":"Yang, F. et al. Curcumin inhibits formation of amyloid; oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem. 280, 5892\u20135901 (2005).","journal-title":"J. Biol. Chem."},{"key":"44818_CR47","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fnmol.2019.00054","volume":"12","author":"J Lu","year":"2019","unstructured":"Lu, J. et al. Structure-based peptide inhibitor design of amyloid-\u03b2 aggregation. Front. Mol. Neurosci. 12, 54 (2019).","journal-title":"Front. Mol. Neurosci."},{"key":"44818_CR48","doi-asserted-by":"publisher","first-page":"13748","DOI":"10.1021\/bi0011330","volume":"39","author":"JJ Balbach","year":"2000","unstructured":"Balbach, J. J. et al. Amyloid fibril formation by A\u03b216-22, a seven-residue fragment of the alzheimer\u2019s \u03b2-amyloid peptide, and structural characterization by solid state NMR. Biochemistry 39, 13748\u201313759 (2000).","journal-title":"Biochemistry"},{"key":"44818_CR49","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.jmb.2007.02.093","volume":"368","author":"NG Sgourakis","year":"2007","unstructured":"Sgourakis, N. G., Yan, Y., McCallum, S. A., Wang, C. & Garcia, A. E. The Alzheimer\u2019s peptides A\u03b240 and 42 adopt distinct conformations in water: a combined MD\/NMR Study. J. Mol. Biol. 368, 1448\u20131457 (2007).","journal-title":"J. Mol. Biol."},{"key":"44818_CR50","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1021\/acschemneuro.9b00602","volume":"11","author":"R Kawai","year":"2020","unstructured":"Kawai, R. et al. Stabilization mechanism for a nonfibrillar amyloid \u03b2 oligomer based on formation of a hydrophobic core determined by dissipative particle dynamics. ACS Chem. Neurosci. 11, 385\u2013394 (2020).","journal-title":"ACS Chem. Neurosci."},{"key":"44818_CR51","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1126\/science.aao2825","volume":"358","author":"L Gremer","year":"2017","unstructured":"Gremer, L. et al. Fibril structure of amyloid-\u03b2(1\u201342) by cryo-electron microscopy. Science 358, 116\u2013119 (2017).","journal-title":"Science"},{"key":"44818_CR52","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3389\/fnins.2018.00464","volume":"12","author":"A Moreno-Garcia","year":"2018","unstructured":"Moreno-Garcia, A. et al. An overview of the role of lipofuscin in age-related neurodegeneration. Front. Neurosci. 12, 464 (2018).","journal-title":"Front. Neurosci."},{"key":"44818_CR53","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley, H. et al. Intraneuronal \u03b2-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129 (2006).","journal-title":"J. Neurosci."},{"key":"44818_CR54","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jalz.2011.03.004","volume":"7","author":"CR Jack Jr","year":"2011","unstructured":"Jack Jr, C. R. et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 7, 257\u2013262 (2011).","journal-title":"Alzheimers Dement."},{"key":"44818_CR55","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman, D. S. et al. Alzheimer disease. Nat. Rev. Dis. Prim. 7, 33 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"44818_CR56","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman, R. J. et al. Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N. Engl. J. Med. 367, 795\u2013804 (2012).","journal-title":"N. Engl. J. Med."},{"key":"44818_CR57","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1001\/jamaneurol.2014.3314","volume":"72","author":"AS Fleisher","year":"2015","unstructured":"Fleisher, A. S. et al. Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study. JAMA Neurol. 72, 316\u2013324 (2015).","journal-title":"JAMA Neurol."},{"key":"44818_CR58","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1146\/annurev-neuro-071013-014300","volume":"37","author":"J-T Yu","year":"2014","unstructured":"Yu, J.-T., Tan, L. & Hardy, J. Apolipoprotein E in Alzheimer\u2019s disease: an update. Annu. Rev. Neurosci. 37, 79\u2013100 (2014).","journal-title":"Annu. Rev. Neurosci."},{"key":"44818_CR59","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","volume":"5","author":"O Hansson","year":"2006","unstructured":"Hansson, O. et al. Association between CSF biomarkers and incipient Alzheimer\u2019s disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol. 5, 228\u2013234 (2006).","journal-title":"Lancet Neurol."},{"key":"44818_CR60","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1001\/jama.2009.1064","volume":"302","author":"N Mattsson","year":"2009","unstructured":"Mattsson, N. et al. CSF biomarkers and incipient alzheimer disease in patients with mild cognitive impairment. JAMA 302, 385\u2013393 (2009).","journal-title":"JAMA"},{"key":"44818_CR61","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1001\/archneurol.2011.105","volume":"68","author":"AM Fagan","year":"2011","unstructured":"Fagan, A. M. et al. Comparison of analytical platforms for cerebrospinal fluid measures of \u03b2-amyloid 1-42, total tau, and P-tau181 for identifying Alzheimer disease amyloid plaque pathology. Arch. Neurol. 68, 1137\u20131144 (2011).","journal-title":"Arch. Neurol."},{"key":"44818_CR62","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3233\/JAD-160573","volume":"55","author":"SP Arneri\u0107","year":"2017","unstructured":"Arneri\u0107, S. P. et al. Cerebrospinal fluid biomarkers for Alzheimer\u2019s disease: a view of the regulatory science qualification landscape from the coalition against major diseases CSF biomarker team. J. Alzheimer\u2019s Dis. 55, 19\u201335 (2017).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"44818_CR63","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack, C. R. et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 14, 535\u2013562 (2018).","journal-title":"Alzheimers Dement."},{"key":"44818_CR64","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","volume":"87","author":"CR Jack","year":"2016","unstructured":"Jack, C. R. et al. A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology 87, 539 (2016).","journal-title":"Neurology"},{"key":"44818_CR65","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3233\/JAD-191331","volume":"75","author":"HJ Lim","year":"2020","unstructured":"Lim, H. J. et al. Comparison of two analytical platforms in cerebrospinal fluid biomarkers for the classification of Alzheimer\u2019s disease spectrum with amyloid PET imaging. J. Alzheimer\u2019s Dis. 75, 949\u2013958 (2020).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"44818_CR66","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3346\/jkms.2010.25.7.1071","volume":"25","author":"H-J Ahn","year":"2010","unstructured":"Ahn, H.-J. et al. Seoul neuropsychological screening battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients. J. Korean Med. Sci. 25, 1071\u20131076 (2010).","journal-title":"J. Korean Med. Sci."},{"key":"44818_CR67","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"MP Lambert","year":"1998","unstructured":"Lambert, M. P. et al. Diffusible, nonfibrillar ligands derived from A\u03b21\u201342 are potent central nervous system neurotoxins. Proc. Natl Acad. Sci. USA 95, 6448\u20136453 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"44818_CR68","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1159\/000496920","volume":"9","author":"JE Park","year":"2019","unstructured":"Park, J. E. et al. Cerebrospinal fluid biomarkers for the diagnosis of prodromal alzheimer\u2019s disease in amnestic mild cognitive impairment. Dement. Geriatr. Cogn. Disord. Extra 9, 100\u2013113 (2019).","journal-title":"Dement. Geriatr. Cogn. Disord. Extra"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-44818-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-44818-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-44818-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T15:03:21Z","timestamp":1706886201000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-44818-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,2]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["44818"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-44818-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2712380\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,2]]},"assertion":[{"value":"20 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1004"}}